Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in severe COVID-19 respiratory disease
NCT04315896Phase 3Completed
- Sponsor
- Instituto Nacional de Enfermedades Respiratorias
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome (SARS), sponsored by Instituto Nacional de Enfermedades Respiratorias. Started Apr 2020; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)severe acute respiratory syndrome (SARS)
Beyond the preview
Go deeper on NCT04315896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04315896.